149 related articles for article (PubMed ID: 38287511)
81. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
[TBL] [Abstract][Full Text] [Related]
82. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
Lin CT; Yen CF; Shaw SW; Yen TC; Chen YJ; Soong YK; Lai CH
Vaccine; 2009 Dec; 27(52):7352-8. PubMed ID: 19781679
[TBL] [Abstract][Full Text] [Related]
83. A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.
Osen W; Peiler T; Ohlschläger P; Caldeira S; Faath S; Michel N; Müller M; Tommasino M; Jochmus I; Gissmann L
Vaccine; 2001 Jul; 19(30):4276-86. PubMed ID: 11457555
[TBL] [Abstract][Full Text] [Related]
84. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.
Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T
Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297
[TBL] [Abstract][Full Text] [Related]
85. A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model.
Qi W; Qingfeng L; Jing Z; Maolin Z; Zhihui Z; Wangqi D; Shanli Z; Jun C; Pengfei J; Lifang Z
Vaccine; 2022 Dec; 40(52):7693-7702. PubMed ID: 36376215
[TBL] [Abstract][Full Text] [Related]
86. HSP70 modified response against HPV based tumor.
Farzanehpour M; Soleimanjahi H; Hassan ZM; Amanzadeh A; Ghaemi A; Fazeli M
Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):228-34. PubMed ID: 23377813
[TBL] [Abstract][Full Text] [Related]
87. Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.
Peng S; Trimble C; Alvarez RD; Huh WK; Lin Z; Monie A; Hung CF; Wu TC
Gene Ther; 2008 Aug; 15(16):1156-66. PubMed ID: 18401437
[TBL] [Abstract][Full Text] [Related]
88. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF
Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417
[TBL] [Abstract][Full Text] [Related]
89. Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
Jindra C; Huber B; Shafti-Keramat S; Wolschek M; Ferko B; Muster T; Brandt S; Kirnbauer R
PLoS One; 2015; 10(9):e0138722. PubMed ID: 26381401
[TBL] [Abstract][Full Text] [Related]
90. In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses.
Kayyal M; Bolhassani A; Noormohammadi Z; Sadeghizadeh M
Mol Biotechnol; 2021 Dec; 63(12):1192-1222. PubMed ID: 34308516
[TBL] [Abstract][Full Text] [Related]
91. mRNA-HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV-mediated cancers via subcutaneous immunization.
Lee S; Yoon H; Hong SH; Kwon SP; Hong JJ; Kwak HW; Park HJ; Yoo S; Bae SH; Park HJ; Lee J; Bang YJ; Lee YS; Kim JY; Yoon S; Roh G; Cho Y; Kim Y; Kim D; Park SI; Kim DH; Lee S; Oh A; Ha D; Lee SY; Park M; Hwang EH; Bae G; Jeon E; Park SH; Choi WS; Oh HR; Kim IW; Youn H; Keum G; Bang EK; Rhee JH; Lee SE; Nam JH
J Med Virol; 2023 Dec; 95(12):e29309. PubMed ID: 38100632
[TBL] [Abstract][Full Text] [Related]
92. The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine.
Wei HJ; Wu AT; Hsu CH; Lin YP; Cheng WF; Su CH; Chiu WT; Whang-Peng J; Douglas FL; Deng WP
Mol Ther; 2011 Dec; 19(12):2249-57. PubMed ID: 21792181
[TBL] [Abstract][Full Text] [Related]
93. Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein.
Liao JB; Publicover J; Rose JK; DiMaio D
Clin Vaccine Immunol; 2008 May; 15(5):817-24. PubMed ID: 18337377
[TBL] [Abstract][Full Text] [Related]
94. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
Moeini S; Saeidi M; Fotouhi F; Mondanizadeh M; Shirian S; Mohebi A; Gorji A; Ghaemi A
Arch Virol; 2017 Feb; 162(2):333-346. PubMed ID: 27699512
[TBL] [Abstract][Full Text] [Related]
95. DNA vaccines for cervical cancer: from bench to bedside.
Hung CF; Monie A; Alvarez RD; Wu TC
Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
[TBL] [Abstract][Full Text] [Related]
96. Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.
Bikorimana JP; Salame N; Beaudoin S; Balood M; Crosson T; Abusarah J; Talbot S; Löbenberg R; Plouffe S; Rafei M
Cell Rep Med; 2022 Mar; 3(3):100534. PubMed ID: 35492876
[TBL] [Abstract][Full Text] [Related]
97. Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNγ-producing cells.
Komatsu A; Igimi S; Kawana K
Vaccine; 2018 Jun; 36(24):3423-3426. PubMed ID: 29735324
[TBL] [Abstract][Full Text] [Related]
98. HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.
Liao SJ; Deng DR; Zeng D; Zhang L; Hu XJ; Zhang WN; Li L; Jiang XF; Wang CY; Zhou JF; Wang SX; Zhang HW; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):735-742. PubMed ID: 24142729
[TBL] [Abstract][Full Text] [Related]
99. Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates.
Rezaei F; Bolhassani A; Sadat SM; Arashkia A; Fotouhi F; Milani A; Pordanjani PM
Life Sci; 2024 Mar; 340():122456. PubMed ID: 38266814
[TBL] [Abstract][Full Text] [Related]
100. Local delivery of accutox
Bikorimana JP; El-Hachem N; Abusarah J; Gonçalves MP; Farah R; Mandl GA; Talbot S; Beaudoin S; Stanga D; Plouffe S; Rafei M
J Transl Med; 2024 Jun; 22(1):532. PubMed ID: 38831284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
